AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The Prostate

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.22461PMID 22127895PMCID PMC3360823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2009

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer

  2008cited by this paper
• Genome-wide promoter analysis uncovers portions of the cancer methylome.

  2008cited by this paper
• Profiling the expression pattern of GPI transamidase complex subunits in human cancer

  2008cited by this paper
• MT1G Hypermethylation Is Associated with Higher Tumor Stage in Prostate Cancer

  2005cited by this paper
• Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy

  2005cited by this paper
• Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

  2005cited by this paper
• A Quantitative Promoter Methylation Profile of Prostate Cancer

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

  2003cited by this paper
• Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

  2003cited by this paper
• Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience.

  2003cited by this paper
• Altered methylation of multiple genes in carcinogenesis of the prostate

  2003influential reference
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

  2003cited by this paper
• Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• Emerging molecular markers of cancer

  2002cited by this paper
• Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.

  2002cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper
• Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Natural history of progression after PSA elevation following radical prostatectomy.

  1999cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996influential reference
• A modified and improved method for bisulphite based cytosine methylation analysis.

  1996cited by this paper
• DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Loss of genes on the short arm of chromosome 11 in bladder cancer

  1985cited by this paper

• Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients

  2023cites this paper
• Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients

  2022cites this paper
• Advances in Prognostic Methylation Biomarkers for Prostate Cancer

  2020cites this paper
• Development and clinical validation of A Novel 9-gene prognostic biomarkers based on multi-omics in pancreatic adenocarcinoma

  2020cites this paper
• Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.

  2020cites this paper
• GSTP1 as a Potential Marker of Early Chemotherapy Response for Noninvasive Detection.

  2019cites this paper
• Plasmacytoid Acinar adenocarcinoma of the prostate: a newly described variant of prostate Cancer.

  2019cites this paper
• Methylation of tumour suppressor genes RUNX3, RASSF1A and E-Cadherin in HCV-related liver cirrhosis and hepatocellular carcinoma

  2019cites this paper
• Purification and Functional Characterization of the C-Terminal Domain of the β-Actin-Binding Protein AIM1 In Vitro

  2018cites this paper
• AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination

  2017cites this paper
• DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

  2016cites this paper
• A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

  2016cites this paper
• GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.

  2014cites this paper
• Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.

  2014cites this paper
• Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer

  2014cites this paper
• Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression

  2013influential citation
• Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence

  2012cites this paper
• Search for DNA Methylation Biomarkers in the Circulating DNA of Prostate and Colorectal Cancer

  2012cites this paper